Indications The dosage of semaglutide can vary significantly, reflecting its broad application across different health conditions and patient groups
If you feel at immediate risk or unable to keep yourself safe, call 999 or go to your nearest A&E department
Gisondi, P., Del Giglio, M., Di Francesco, V., Zamboni, M
Indications and Usage Saxenda (liraglutide) injection 3 mg is indicated in combination with reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in: Adults and pediatric patients aged 12 years and older with body weight greater than 60kg and obesity Adults with overweight in the presence of at least one weight related comorbid condition Limitations of Use Saxenda contains liraglutide and should not be coadministered with other liraglutide-containing products or with any other GLP-1 receptor agonist The safety and effectiveness of Saxenda in pediatric patients with type 2 diabetes have not been established References 1
Michael Calore: All this month WIRED is running a special series on our website about the booming business and latest science of anti-obesity drugs
MeAgain is built for the full GLP-1 journey: shot day, food, symptoms, progress, medication context, and support in one place
